CORMUNE
LIVE

Serial Number

88867322

Owner

CHANDLER BIOPHARMACEUTICAL INC.

First Use Date

Jan 1, 2020

Filing Date

Apr 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CORMUNE Trademark

Serial Number: 88867322 • Registration: 6296869

CORMUNE is a trademark filed by CHANDLER BIOPHARMACEUTICAL INC. on April 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CHANDLER BIOPHARMACEUTICAL INC.

ELKHART, IN 46516

Entity Type: 03

Trademark Details

Filing Date

April 10, 2020

Registration Date

March 16, 2021

First Use Anywhere

January 1, 2020

First Use in Commerce

June 26, 2020

Published for Opposition

August 11, 2020

Goods & Services

Anti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-inflammatories; Anti-inflammatory preparations; Antidiabetic preparations; Antihistamines; Antivirals; Dietary supplements; Dietary supplements for pets; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Food for babies; Food for infants; Food supplements; Medical dressings; Medical plasters; Medicated dentifrices; Medicated shampoo; Medicated shampoos; Medicated soap; Medicated soaps; Medicated sweets; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplement energy bars; Nutritional supplement for eliminating toxins from the body; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplement shakes; Nutritional supplements; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritional supplements in the nature of nutritionally fortified soft chews; Nutritionally fortified beverages for medical purposes; Nutritive substances for micro-organisms for medical use; Nutritive substances for microorganism cultures; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, antidepressants; Prebiotic supplements; Probiotic animal feed; Probiotic preparations for medical use; Probiotic supplements; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers; Vaccines; Vaccines against flu; Vaccines against pneumococcal infections; Vaccines for cattle; Vaccines for horses; Adjuvants for use with vaccines; Amino acids for nutritional purposes; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed additives for use as nutritional supplements; Baby food; Candy, medicated; Central nervous system stimulants; Cultures of microorganisms for medical or veterinary use; Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary supplement for eliminating toxins from the intestinal tract; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Gastro-intestinal treatment preparations; Hair growth stimulants; Human vaccine preparations; Ketogenic dietary and nutritional supplements; Ketogenic dietary and nutritional supplements used for weight loss; Liquid nutritional supplement; Medicated mouth care and treatment preparations; Medicated mouth washes; Medicated anti-cavity mouth rinses; Medicines for intestinal disorders; Mineral nutritional supplements; Natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Non-medicated additives for animal feed for use as nutritional supplements; Nutritional supplement for eliminating toxins from the intestinal tract; Nutritional supplements, namely, probiotic compositions; Nutritive substances for microorganisms for medical purposes; Oral vaccine preparations; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Respiratory stimulants; Therapeutic vaccines; Vegan protein for use as a nutritional supplement in ready-to-drink beverages; Veterinary vaccine for horses; Veterinary vaccines; Veterinary preparations for treatment of intestinal bacteria

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 16, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 16, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 12, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 11, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 19, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 19, 2021 AITU
USE AMENDMENT FILED
Dec 30, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 30, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 6, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 11, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2020 CNSA
ASSIGNED TO EXAMINER
Jun 28, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 19, 2020 NWOS
NEW APPLICATION ENTERED
Apr 14, 2020 NWAP